BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 20398809)

  • 21. MYC and aggressive B-cell lymphomas.
    Slack GW; Gascoyne RD
    Adv Anat Pathol; 2011 May; 18(3):219-28. PubMed ID: 21490439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation.
    Ruzinova MB; Caron T; Rodig SJ
    Am J Surg Pathol; 2010 Jun; 34(6):882-91. PubMed ID: 20442643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffuse large B-cell lymphomas and burkitt lymphoma.
    de Leval L; Hasserjian RP
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):791-827. PubMed ID: 19577170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma.
    Haralambieva E; Boerma EJ; van Imhoff GW; Rosati S; Schuuring E; Müller-Hermelink HK; Kluin PM; Ott G
    Am J Surg Pathol; 2005 Aug; 29(8):1086-94. PubMed ID: 16006805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
    Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
    Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
    Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
    Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New developments in non-Hodgkin lymphoid malignancies.
    Ganapathi KA; Brown LE; Prakash S; Bhargava P
    Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.
    Swerdlow SH
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):90-9. PubMed ID: 25696840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathology consultation on intermediate-to-large B-cell lymphomas.
    Montgomery ND; Fedoriw Y
    Am J Clin Pathol; 2014 Mar; 141(3):305-17. PubMed ID: 24515757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues.
    Grimm KE; O'Malley DP
    Ann Diagn Pathol; 2019 Feb; 38():6-10. PubMed ID: 30380402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular heterogeneity of B-lineage diffuse large cell lymphoma.
    Volpe G; Vitolo U; Carbone A; Pastore C; Bertini M; Botto B; Audisio E; Freilone R; Novero D; Cappia S; De Giuli P; Mazza U; Resegotti L; Palestro G; Saglio G; Gaidano G
    Genes Chromosomes Cancer; 1996 May; 16(1):21-30. PubMed ID: 9162193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
    Nam-Cha SH; Roncador G; Sanchez-Verde L; Montes-Moreno S; Acevedo A; Domínguez-Franjo P; Piris MA
    Am J Surg Pathol; 2008 Aug; 32(8):1252-7. PubMed ID: 18594468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.
    Huebner-Chan D; Fernandes B; Yang G; Lim MS
    Mod Pathol; 2001 Oct; 14(10):1000-7. PubMed ID: 11598170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles.
    Almasri NM; Iturraspe JA; Braylan RC
    Arch Pathol Lab Med; 1998 Jun; 122(6):539-44. PubMed ID: 9625422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Double-Hit" mature B-cell lymphomas show a common immunophenotype by flow cytometry that includes decreased CD20 expression.
    Wu D; Wood BL; Dorer R; Fromm JR
    Am J Clin Pathol; 2010 Aug; 134(2):258-65. PubMed ID: 20660329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Non-Hodgkin's lymphoma and AIDS: histopathologic features].
    Raphael M; Lamine M; Abd Alsamad I; Debré P; Binet JL
    Arch Anat Cytol Pathol; 1992; 40(2-3):105-9. PubMed ID: 1449258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin's disease: classification and differential diagnosis.
    Harris NL
    Mod Pathol; 1999 Feb; 12(2):159-75. PubMed ID: 10071341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD23 expression in mediastinal large B-cell lymphomas.
    Calaminici M; Piper K; Lee AM; Norton AJ
    Histopathology; 2004 Dec; 45(6):619-24. PubMed ID: 15569053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [World Health Organization (WHO) classification of malignant lymphoma--how is the WHO now?].
    Nakamura S
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):149-57. PubMed ID: 14997743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases.
    Perry AM; Crockett D; Dave BJ; Althof P; Winkler L; Smith LM; Aoun P; Chan WC; Fu K; Greiner TC; Bierman P; Gregory Bociek R; Vose JM; Armitage JO; Weisenburger DD
    Br J Haematol; 2013 Jul; 162(1):40-9. PubMed ID: 23600716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.